These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

486 related items for PubMed ID: 19208462

  • 41. Design, synthesis and biological evaluation of new potent and highly selective ROS1-tyrosine kinase inhibitor.
    Park BS, El-Deeb IM, Yoo KH, Oh CH, Cho SJ, Han DK, Lee HS, Lee JY, Lee SH.
    Bioorg Med Chem Lett; 2009 Aug 15; 19(16):4720-3. PubMed ID: 19596575
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. A general framework for inhibitor resistance in protein kinases.
    Balzano D, Santaguida S, Musacchio A, Villa F.
    Chem Biol; 2011 Aug 26; 18(8):966-75. PubMed ID: 21867912
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Chemical kinomics: a powerful strategy for target deconvolution.
    Kim DH, Sim T.
    BMB Rep; 2010 Nov 26; 43(11):711-9. PubMed ID: 21110913
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. New light for science: synchrotron radiation in structural medicine.
    Sorensen TL, McAuley KE, Flaig R, Duke EM.
    Trends Biotechnol; 2006 Nov 26; 24(11):500-8. PubMed ID: 17005277
    [Abstract] [Full Text] [Related]

  • 51. Bruton's tyrosine kinase as a drug discovery target.
    Pan Z.
    Drug News Perspect; 2008 Sep 26; 21(7):357-62. PubMed ID: 19259548
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Structure-based chemogenomics: analysis of protein family landscapes.
    Pirard B.
    Methods Mol Biol; 2009 Sep 26; 575():281-96. PubMed ID: 19727620
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Protein kinases: From targets to anti-cancer drugs.
    Cruzalegui F.
    Ann Pharm Fr; 2010 Jul 26; 68(4):254-9. PubMed ID: 20637357
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Discovery and optimization of indazoles as potent and selective interleukin-2 inducible T cell kinase (ITK) inhibitors.
    Pastor RM, Burch JD, Magnuson S, Ortwine DF, Chen Y, De La Torre K, Ding X, Eigenbrot C, Johnson A, Liimatta M, Liu Y, Shia S, Wang X, Wu LC, Pei Z.
    Bioorg Med Chem Lett; 2014 Jun 01; 24(11):2448-52. PubMed ID: 24767842
    [Abstract] [Full Text] [Related]

  • 59. Anchor-based classification and type-C inhibitors for tyrosine kinases.
    Hsu KC, Sung TY, Lin CT, Chiu YY, Hsu JT, Hung HC, Sun CM, Barve I, Chen WL, Huang WC, Huang CT, Chen CH, Yang JM.
    Sci Rep; 2015 Jun 16; 5():10938. PubMed ID: 26077136
    [Abstract] [Full Text] [Related]

  • 60. Chemical genetic approaches to kinase drug discovery.
    Gallion SL, Qian D.
    Curr Opin Drug Discov Devel; 2005 Sep 16; 8(5):638-45. PubMed ID: 16159026
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.